Europe Acetaminophen Reagents Market

Market Introduction

The Europe acetaminophen reagents market includes the consolidated markets for Germany, France, Italy, Spain, UK, and Rest of Europe. Germany led the market in 2021. In Germany, ibuprofen, naproxen, and paracetamol are widely available OTC at offline and internet pharmacies. The wide availability of the drugs leads to intentional or unintentional overdose that affects the body and its functioning. Acetaminophen toxicity may lead to acute liver failure, although various risk factors raise the probability of acute liver damage, such as alcohol and the intake of such substances increase the risk of liver failure after consuming acetaminophen. An acute liver failure is a severe form of acute liver injury that can progress to multiple organs and causes their failure. The overall incidence of acute liver failure in developed countries on a yearly basis was found to be 1–6 per million people. In Germany, almost 200 to 500 cases of acute liver failure occur annually and affect women more than men, and account for 52% to 63% of cases. Furthermore, Germany invests significantly in healthcare research and infrastructure among all the nations that are a part of the European Union. According to the Federal Statistical Office, health expenditure in Germany accounted to US$ 460.03 billion in 2019, which was one of the highest healthcare expenditures for healthcare among the relative EU member states. This can be related to the high capital investments dedicated to the development, research, and manufacturing of advanced products and solutions, thus expected to drive the growth of the acetaminophen reagents market in the country. Therefore, dosage management is required to prevent acetaminophen toxicity and acute liver failure due to acetaminophen. This will propel the testing demand that will favor the growth of the acetaminophen reagents market in the forecast period.

In case of COVID-19, Europe is highly affected specially the UK.  The European region is severely affected due to the exponential growth of the COVID-19 pandemic like other parts of the planet. As per the European Centre for Disease Prevention and Control (ECDC), bans have been reintroduced due to the second wave of COVID-19 crises in the UK, Spain, and Italy. The rising occurrence rate of coronavirus results in increased stress on the region's healthcare system, raising the demand for diagnostic tests in its healthcare system, supporting the expansion of the sector in this region.  The acetaminophen reagents market witnessed a shortfall at the beginning of the COVID-19 crisis due to disruption in the supply chain and slumped demand due to the lockdown announced by most European countries that caused disruptions in manufacturing and operations in the pharmaceutical sector. Additionally, appointments and operations have been delayed in many clinics around the world due to increasing cases, as approximately 40% of the diagnosed COVID-19 cases required hospitalization; and some critical cases were admitted to intensive care units (ICU). With the number of rising cases, there was a significant decrease in procedures due to a lack of healthcare resources. It also impacted the new product launches, impacting sales and growth of the market in the region. However, with the implementation of proper guidelines and protocols by the European Commission to reduce SARS-CoV-2 exposure and ease in restrictions on movement, the market is expected to grow in the forecast period.

Market Overview and Dynamics

The Europe acetaminophen reagents market is expected to grow from US$ 164.88 million in 2021 to US$ 222.79 million by 2028; it is estimated to grow at a CAGR of 4.4% from 2021 to 2028. Continuous medical science improvements and technological advancements result in extending longevity and improved quality of life. Immunoassays are widely used in various areas of pharmaceutical analysis, such as disease diagnosis and therapeutic drug monitoring. The immunoassay methods are used significantly in the analysis due to their inherent specificity, high throughput, and high sensitivity for analyzing a wide range of analytes in samples. Recent improvements in immunoassay development for pharmaceutical analysis involve the preparation of unique immunoanalytical reagents, new categories of compounds, and instrumentation. The analysis of blood, serum, or urine through immunoassay methods can be achieved without pretreatment for the sample. The development of a new immunoassay method may take longer due to the time required for generating the desired antibody. However, once suitable immunoanalytical reagents are developed, the immunoassay method can be performed easily within a time frame. The technological advancement in immunoassay-based acetaminophen reagents includes Siemens Healthcare ADVIA 2400 chemistry system, an advanced chemistry analyzer that offers more advantages over enzymatic assay. Several manufacturing companies operating in the market are developing advanced acetaminophen reagents and assays, such as Emit tox acetaminophen assay, a homogeneous enzyme immunoassay to be used for quantitative analysis of acetaminophen in human serum or plasma. These reagents are packaged specifically to use on various AU Clinical Chemistry Systems. Therefore, the developments mentioned above would result in significant trends in the Europe acetaminophen reagents market during the forecast period.

Key Market Segments

In terms of product, the antibody/substrate reagent segment accounted for the largest share of the Europe acetaminophen reagents market in 2020. In terms of application, the enzymatic assays segment held a larger market share of the Europe acetaminophen reagents market in 2020. Further, the hospitals segment held a larger share of the Europe acetaminophen reagents market based on end user in 2020.  

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the Europe acetaminophen reagents market are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Abbott; American Screening Corporation, Inc.; Beckman Coulter, Inc.; Bio-Rad Laboratories, Inc.; Biorbyt Ltd.; EKF Diagnostics; Randox Laboratories, Ltd.; Sekisui Diagnostics; Siemens Healthineers AG; and Thermo Fisher Scientific Inc. among others.

Reasons to buy report

• To understand the Europe acetaminophen reagents market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe acetaminophen reagents market
• Efficiently plan M&A and partnership deals in Europe acetaminophen reagents market by identifying market segments with the most promising probable sales  
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe acetaminophen reagents market
• Obtain market revenue forecast for market by various segments from 2021-2028 in Europe region.

Europe Acetaminophen Reagents Market Segmentation

Europe Acetaminophen Reagents Market - By Product

• Antibody/Substrate Reagent
• Enzyme Reagent
• Acetaminophen Antiserum
• Acetaminophen Fluorescein Tracer
• Pretreatment Solution

Europe Acetaminophen Reagents Market -

By Application

• Enzymatic Assays
• Immunoassay 

Europe Acetaminophen Reagents Market -

By End User

• Hospitals
• Diagnostics Laboratories
• POC Testing
• Forensic Laboratories
• Others

Europe Acetaminophen Reagents Market - By Country

• Germany   
• France 
• UK
• Italy
• Spain
• Rest of Europe

Europe Acetaminophen Reagents Market - Company Profiles

• Abbott
• American Screening Corporation, Inc.
• Beckman Coulter, Inc.
• Bio-Rad Laboratories, Inc.
• Biorbyt Ltd.         
• EKF Diagnostics
• Randox Laboratories, Ltd.
• Sekisui Diagnostics  
• Siemens Healthineers AG     
• Thermo Fisher Scientific Inc.

Europe Acetaminophen Reagents Strategic Insights

Strategic insights for the Europe Acetaminophen Reagents provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Europe Acetaminophen Reagents Report Scope

Europe Acetaminophen Reagents Regional Insights

The geographic scope of the Europe Acetaminophen Reagents refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.